Page 154 - IJB-10-5
P. 154

International Journal of Bioprinting                               Liver printing: from structure to application




               doi: 10.1038/ncpgasthep0254                     78.  Harrison SP, Baumgarten SF, Verma R, Lunov O, Dejneka
                                                                  A, Sullivan GJ. Liver organoids: recent developments,
            66.  Krisper P, Stauber RE. Technology insight: artificial
               extracorporeal liver support—how does Prometheus®   limitations and potential.  Front Med  (Lausanne).
               compare with MARS®? Nat Clin Pract Nephrol. 2007;3(5):   2021;8:574047.
               267-276.                                           doi: 10.3389/fmed.2021.574047
               doi: 10.1038/ncpneph0466                        79.  Hu H, Gehart H, Artegiani B, et al. Long-term expansion of
                                                                  functional mouse and human hepatocytes as 3D organoids.
            67.  Strain AJ, Neuberger JM. A bioartificial liver--state of the
               art. Science. 2002;295(5557):1005-1009.            Cell. 2018;175(6):1591-1606.e19.
               doi: 10.1126/science.1068660                       doi: 10.1016/j.cell.2018.11.013
                                                               80.  Huch M, Dorrell C, Boj SF, et al. In vitro expansion of single
            68.  Glorioso JM, Mao SA, Rodysill B, et al. Pivotal preclinical
               trial of the spheroid reservoir bioartificial liver. J Hepatol.   Lgr5+ liver stem cells induced by Wnt-driven regeneration.
               2015;63(2):388-398.                                Nature. 2013;494(7436):247-250.
               doi: 10.1016/j.jhep.2015.03.021                    doi: 10.1038/nature11826
                                                               81.  Huch M, Gehart H, van Boxtel R, et al. Long-term culture of
            69.  Li Y, Wu Q, Wang Y, et al. Novel spheroid reservoir
               bioartificial liver improves survival of nonhuman primates   genome-stable bipotent stem cells from adult human liver.
               in a toxin-induced model of acute liver failure. Theranostics.   Cell. 2015;160(1):299-312.
               2018;8(20):5562-5574.                              doi: 10.1016/j.cell.2014.11.050
               doi: 10.7150/thno.26540                         82.  Vyas D, Baptista PM, Brovold M, et al. Self‐assembled liver
                                                                  organoids recapitulate hepatobiliary organogenesis in vitro.
            70.  Thompson J, Jones N, Al‐Khafaji A, et al. Extracorporeal
               cellular therapy (ELAD)  in severe alcoholic  hepatitis:  a   Hepatology. 2018;67(2):750-761.
               multinational, prospective, controlled, randomized trial.      doi: 10.1002/hep.29483
               Liver Transpl. 2018;24(3):380-393.              83.  Takebe T, Sekine K, Enomura M, et al. Vascularized and
               doi: 10.1002/lt.24986                              functional human liver from an iPSC-derived organ bud
                                                                  transplant. Nature. 2013;499(7459):481-484.
            71.  Chen S, Wang J, Ren H, et al. Hepatic spheroids derived
               from human induced pluripotent stem cells in bio-artificial      doi: 10.1038/nature12271
               liver rescue porcine acute liver failure.  Cell Res. 2020;   84.  Wu F, Wu D, Ren Y, et al. Generation of hepatobiliary
               30(1):95-97.                                       organoids from human induced pluripotent stem cells.  J
               doi: 10.1038/s41422-019-0261-5                     Hepatol. 2019;70(6):1145-1158.
                                                                  doi: 10.1016/j.jhep.2018.12.028
            72.  Li  W-J, Zhu X-J,  Yuan T-J, et  al. An  extracorporeal
               bioartificial liver embedded with 3D-layered human liver   85.  Sorrentino G, Rezakhani S, Yildiz E, et al. Mechano-
               progenitor-like cells relieves acute liver failure in pigs. Sci   modulatory synthetic niches for liver organoid derivation.
               Transl Med. 2020;12(551):eaba5146.                 Nat Commun. 2020;11(1):3416.
               doi: 10.1126/scitranslmed.aba5146                  doi: 10.1038/s41467-020-17161-0
            73.  Wang Y, Zheng Q, Sun Z, et al. Reversal of liver failure using   86.  Zhang S, Xu G, Wu J, et al. Microphysiological constructs
               a bioartificial liver device implanted with clinical-grade   and systems: biofabrication tactics, biomimetic evaluation
               human-induced hepatocytes. Cell Stem Cell. 2023;30(5):617-  approaches, and biomedical applications.  Small Methods.
               631.e8.                                            2024;8(1):2300685.
               doi: 10.1016/j.stem.2023.03.013                    doi: 10.1002/smtd.202300685
            74.  Shi X-L, Gao Y, Yan Y, et al. Improved survival of porcine   87.  Zhang B, Korolj A, Lai BFL, Radisic M. Advances in organ-
               acute liver failure by a bioartificial liver device implanted   on-a-chip engineering. Nat Rev Mater. 2018;3(8):257-278.
               with induced human functional hepatocytes.  Cell Res.      doi: 10.1038/s41578-018-0034-7
               2016;26(2):206-216.                             88.  Leung CM, de Haan P, Ronaldson-Bouchard K, et al. A guide to
               doi: 10.1038/cr.2016.6
                                                                  the organ-on-a-chip. Nat Rev Methods Primers. 2022;2(1):33.
            75.  Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater.      doi: 10.1038/s43586-022-00118-6
               2021;6(5):402-420.                              89.  Ingber DE. Human organs-on-chips for disease modelling,
               doi: 10.1038/s41578-021-00279-y
                                                                  drug development and personalized medicine.  Nat Rev
            76.  Zhao Z, Chen X, Dowbaj AM, et al. Organoids.  Nat Rev   Genet. 2022;23(8):467-491.
               Methods Primers. 2022;2(1):94.                     doi: 10.1038/s41576-022-00466-9
               doi: 10.1038/s43586-022-00174-y
                                                               90.  Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA.
            77.  Rossi G, Manfrin A, Lutolf MP. Progress and potential in   Organs-on-chips: into the next decade. Nat Rev Drug Discov.
               organoid research. Nat Rev Genet. 2018;19(11):671-687.  2021;20(5):345-361.
               doi: 10.1038/s41576-018-0051-9                     doi: 10.1038/s41573-020-0079-3


            Volume 10 Issue 5 (2024)                       146                                doi: 10.36922/ijb.3819
   149   150   151   152   153   154   155   156   157   158   159